��������

Vlad Seitan has a diverse work experience in the field of scientific research. Vlad is currently serving as the Chief Scientific Officer at Laverock Therapeutics since December 2020. Prior to this, they held various roles at King's College London, including Visiting Research Fellow since December 2020 and Research Group Leader from February 2015 to December 2020. Vlad began their career as a Postdoctoral Fellow at the Clinical Sciences Centre MRC UK, where they worked from December 2008 to December 2014.

Vlad Seitan pursued their education in the field of Molecular Biology. From 2002 to 2004, they attended The University of Edinburgh and obtained a Bachelor's Degree in Biological Sciences/Molecular Biology. Vlad further continued their academic journey and enrolled at Newcastle University from 2004 to 2008, where they earned a Doctor of Philosophy (Ph.D.) in Molecular Biology.